|
시장보고서
상품코드
2129024
헤파린 칼슘 시장 : 제품 유형별, 투여 경로별, 용도별, 최종 사용자별, 국가별, 지역별 - 업계 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)Heparin Calcium Market, By Product Type, By Route of Administration, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033 |
||||||
헤파린 칼슘 시장 규모는 2025년에 15억 8,070만 달러로 평가되었고, 2026-2033년 CAGR 3.1%로 성장할 전망입니다.
헤파린 칼슘은 항트롬빈 III의 활성을 높여 트롬빈 및 제Xa 인자 등 중요한 응고 인자를 억제하는 음전하를 띤 글리코사미노글리칸계 항응고제입니다. 심부정맥 혈전증(DVT), 폐색전증(PE) 및 기타 응고 관련 질환은 예방 및 치료에 일반적으로 사용되는 혈전색전성 질환의 일부입니다. 또한, 헤파린 칼슘은 체외 순환, 혈액 투석 및 혈전 예방 관리가 필요한 기타 치료에서 항응고 상태를 유지하기 위해 빈번하게 사용됩니다.
헤파린 칼슘 시장 : 시장 역학
혈전색전성 질환 및 심혈관 질환의 유병률 증가, 그리고 외과 수술 및 신장 투석 건수 증가가 시장 수요를 견인할 것으로 예측됩니다.
심부정맥 혈전증(DVT), 폐색전증(PE), 심혈관 질환 및 기타 혈전색전성 질환으로 인한 부담 증가는 헤파린 칼슘 시장 수요를 뒷받침하는 중요한 요인이 되고 있습니다. 세계보건기구(WHO) 보고서에 따르면, 심혈관 질환은 여전히 전 세계 사망 원인 1위를 차지하고 있으며, 연간 약 1,800만 명의 사망 원인이 되고 있어 효율적인 항응고 치료의 필요성이 매우 높다는 점이 부각되고 있습니다. 헤파린 칼슘은 중요한 응고 인자, 특히 트롬빈과 제Xa 인자를 억제하는 항트롬빈 III의 활성을 높임으로써 신속한 항응고 효과를 발휘합니다. 따라서 대수술, 입원, 혈액 투석 및 혈전색전성 질환 치료를 받는 환자 수 증가가 헤파린계 항응고제에 대한 수요를 뒷받침하고 있습니다. 심부정맥혈전증(DVT), 폐색전증, 심방세동 등의 질환에 대한 지속적인 항응고 요법 수요 역시 헤파린 시장 전체의 확장을 견인하는 요인 중 하나입니다.
헤파린 칼슘 시장은 신장 투석 서비스의 확대와 외과 수술 건수 증가에 의해서도 견인되고 있습니다. 헤파린 칼슘은 혈액 투석이나 체외 순환 중 혈전 형성을 방지하기 위해 빈번하게 사용되므로, 병원, 투석 센터 및 전문 치료 시설이 주요 최종 사용자가 되고 있습니다. 정기적이거나 장기적인 투석을 받는 환자 수가 증가함에 따라, 체외 순환 회로를 통한 지속적인 혈류를 유지하고 치료 중 혈전 형성을 방지하기 위해서는 신뢰성 높은 항응고제가 필요합니다. 또한, 혈전색전증의 위험을 줄이기 위해 항응고 요법이 필요한 심혈관 외과 및 정형외과 수술 등의 시술 건수 증가 역시 근골격계 질환 및 심혈관 질환의 발생 빈도가 높아지고 있는 결과입니다.
헤파린 칼슘 시장 : 시장 세분화 분석
세계 헤파린 칼슘 시장은 제품 유형, 투여 경로, 용도, 최종 사용자 및 지역을 기준으로 세분화됩니다.
시장은 제품 유형에 따라 비분획 헤파린(UFH), 저분자량 헤파린(LMWH), 기타 3가지 범주로 분류됩니다. 비분획 헤파린(UFH)은 헤파린 칼슘 시장에서 중요한 제품 유형 부문입니다. UFH는 분자량이 다른 다당류 사슬의 불균일한 혼합물로 구성되어 있으며, 주로 항트롬빈 III의 활성을 높여 항응고 작용을 발휘함으로써 트롬빈 및 제Xa 인자 등의 주요 응고 인자를 억제합니다. 헤파린 칼슘은 헤파린의 칼슘염으로, 임상용 주사용 항응고제로 제제화되어 있습니다.
헤파린 칼슘 시장 : 지역별 분석
유럽은 확립된 제약 산업, 엄격한 품질 및 규제 기준, 선진적인 의료 인프라, 그리고 전문 헤파린 제조업체의 존재에 힘입어 헤파린 칼슘 시장에서 중요한 지역으로 자리 잡고 있습니다. 북미는 대규모의 첨단 의료 시스템, 다수의 내과 및 외과 치료, 심혈관 질환 관리에 대한 수요 증가, 그리고 광범위한 신장 투석 서비스를 갖추고 있습니다. 이 지역의 헤파린 칼슘 제품에 대한 수요는 확립된 의약품 공급망과 병원 및 전문 의료시설에서의 주사용 항응고제 지속적 사용에 의해 더욱 뒷받침되고 있습니다. 아시아태평양에서는 헤파린 및 그 파생 제품이 대량으로 생산·소비되고 있습니다. 중국에는 Hepalink, Dongcheng Pharmaceutical, Changshan Pharmaceutical과 같은 유서 깊은 제약 기업의 지원을 받아 헤파린 원료의약품(API) 및 중간체에 관한 대규모 제조 거점이 있습니다.
목차
제1장 헤파린 칼슘 시장 개요
제2장 주요 요약
제3장 헤파린 칼슘 주요 시장 동향
제4장 헤파린 칼슘 산업 분석
제5장 헤파린 칼슘 시장 : 높아지는 지정학적 긴장의 영향
제6장 헤파린 칼슘 시장 구도
제7장 헤파린 칼슘 시장 : 제품 유형별
제8장 헤파린 칼슘 시장 : 투여 경로별
제9장 헤파린 칼슘 시장 : 용도별
제10장 헤파린 칼슘 시장 : 최종 사용자별
제11장 헤파린 칼슘 시장 : 지역별
제12장 주요 벤더 분석 : 헤파린 칼슘 산업
제13장 AnalystView 전방위 전망
AJY 26.09.17Heparin Calcium Market size was valued at USD 1,580.7 Million in 2025, expanding to a CAGR of 3.1% from 2026 to 2033.
Heparin calcium is a negatively charged glycosaminoglycan anticoagulant that inhibits important coagulation factors like thrombin and factor Xa by increasing the activity of antithrombin III. Deep vein thrombosis (DVT), pulmonary embolism (PE), and other clotting-related illnesses are among the thromboembolic disorders that it is commonly used to prevent and treat. Additionally, heparin calcium is frequently used to maintain anticoagulation during extracorporeal circulation, hemodialysis, and other medical treatments that call for regulated blood clot prevention.
Heparin Calcium Market- Market Dynamics
Growing prevalence of thromboembolic and cardiovascular disorders and rising surgical, renal dialysis are expected to propel market demand
The growing burden of deep vein thrombosis (DVT), pulmonary embolism (PE), cardiovascular diseases, and other thromboembolic disorders is a key factor supporting demand for the heparin calcium market. The World Health Organization (WHO) reports that cardiovascular illnesses continue to be the leading cause of death worldwide, accounting for almost 18 million deaths annually, underscoring the critical need for efficient anticoagulation treatments. By boosting the activity of antithrombin III, which inhibits important coagulation factors, especially thrombin and factor Xa, heparin calcium offers quick anticoagulant effect. The need for heparin-based anticoagulants is thus being supported by the growing number of patients undergoing major operations, hospital stays, hemodialysis, and therapy for thromboembolic illnesses. The ongoing requirement for anticoagulation in diseases including DVT, pulmonary embolism, atrial fibrillation, etc. is another factor driving the larger heparin market.
The market for heparin calcium is also being driven by the growth of renal dialysis services and the increasing number of surgical procedures. Hospitals, dialysis centres, and specialized treatment facilities are important end users of heparin calcium because it is frequently used to prevent blood clot formation during hemodialysis and extracorporeal circulation. Reliable anticoagulants are necessary to sustain continuous blood flow through extracorporeal circuits and avoid clot formation during therapy, as the number of patients receiving regular or long-term dialysis rises. Increased procedural volumes, such as cardiovascular and orthopedic surgeries, where anticoagulation may be necessary to reduce thromboembolic risks, are also a result of the rising frequency of musculoskeletal disorders and cardiovascular diseases.
Heparin Calcium Market- Segmentation Analysis:
The Global Heparin Calcium Market is segmented on the basis of Product Type, Route of Administration, Application, End User, and Region.
The market is divided into three categories based on Product Type: Unfractionated Heparin (UFH), Low Molecular Weight Heparin (LMWH), and others. Unfractionated heparin (UFH) is a significant product type segment in the heparin calcium market. UFH comprises a heterogeneous mixture of polysaccharide chains with varying molecular weights and exerts its anticoagulant effect primarily by enhancing the activity of antithrombin III, thereby inhibiting key coagulation factors such as thrombin and factor Xa. Heparin calcium is the calcium salt form of heparin and is formulated as an injectable anticoagulant for clinical applications.
Heparin Calcium Market- Geographical Insights
Europe is an important region in the heparin calcium market, supported by its well-established pharmaceutical industry, stringent quality and regulatory standards, advanced healthcare infrastructure, and presence of specialized heparin manufacturers. North America has a sizable and sophisticated healthcare system, a high number of medical and surgical treatments, a growing need to control cardiovascular disease, and a wide range of renal dialysis services. The need for heparin calcium products is further supported by the region's well-established pharmaceutical supply chain and the ongoing usage of injectable anticoagulants in hospitals and specialized care settings. Heparin and products derived from it are produced and consumed in large quantities in Asia-Pacific. China has a substantial manufacturing base for heparin APIs and intermediates, supported by established pharmaceutical companies such as Hepalink, Dongcheng Pharmaceutical, and Changshan Pharmaceutical.
India Heparin Calcium Market- Key Insights
With increased healthcare spending, expanding pharmaceutical manufacturing, rising surgical volumes, and an increasing need for anticoagulant treatments, India offers a substantial potential opportunity for the heparin calcium industry. Heparin-based products are in high demand in hospitals and specialized healthcare facilities due to the rising incidence of cardiovascular diseases, thromboembolic disorders, and chronic renal disease. Heparin APIs, injectable anticoagulants, and pharmaceutical-grade raw materials are all in constant demand due to India's sizable and reasonably priced pharmaceutical manufacturing base. Additionally, the use of anticoagulants during hemodialysis and extracorporeal treatments is rising due to the growth of renal dialysis facilities and hospital infrastructure, especially in tier-2 and tier-3 cities.
Heparin Calcium Market- Competitive Landscape:
The heparin calcium market is highly competitive and comprises specialized heparin API manufacturers, pharmaceutical companies, biopharmaceutical companies, and vertically integrated anticoagulant producers. API purity, raw-material traceability, manufacturing consistency, regulatory compliance, supply dependability, production capacity, cost effectiveness, and quality control are all factors that drive market competition. Getting regulatory clearances and increasing access to foreign markets are two more significant areas of rivalry. Businesses are expanding their portfolios of heparin-based anticoagulant medications and fortifying their international distribution networks. For instance, Hepalink has grown its finished-product business connected to heparin across Europe, North America, Asia, Latin America, and other international markets. The company's enoxaparin sodium injection was approved by South Africa and Argentina in 2025, which helped it enter new international markets.
Recent Developments:
In September 2025, Yino Pharma continued its presence in the global heparin API market, with expanding manufacturing operations in China and capabilities spanning heparin raw-material processing and API production.
In January 2025, Opocrin maintained its pharmaceutical API manufacturing activities, supported by its certified production capabilities for APIs derived from animal organs. The company offers a heparin portfolio that includes heparin calcium and heparin sodium, with its heparin calcium derived from porcine intestinal material.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HEPARIN CALCIUM MARKET KEY PLAYERS
- Shenzhen Hepalink Pharmaceutical Co., Ltd.
- Changshan Pharmaceutical
- Dongcheng Pharmaceutical
- Cisen Pharmaceutical
- Changzhou Qianhong Biopharma
- Nanjing King-friend Biochemical Pharmaceutical
- Yino Pharma Limited
- Tianjin Chasesun Pharmaceutical
- Bioiberica
- Opocrin S.p.A.
- Sichuan Deebio Pharmaceutical
- Dongying Tiandong Pharmaceutical
- Nanjing Xinbai Pharmaceutical
- Qingdao Jiulong Biopharmaceutical
- Pfizer Inc.
- Others
GLOBAL HEPARIN CALCIUM MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020-2033
- Unfractionated Heparin (UFH)
- Low Molecular Weight Heparin (LMWH)
- Others
GLOBAL HEPARIN CALCIUM MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2020-2033
- Subcutaneous Injection
- Intravenous
- Others
GLOBAL HEPARIN CALCIUM MARKET, BY APPLICATION- MARKET ANALYSIS, 2020-2033
- Deep Vein Thrombosis
- Pulmonary Embolism
- Renal Dialysis
- Cardiovascular Surgery
- Others
GLOBAL HEPARIN CALCIUM MARKET, BY END USER- MARKET ANALYSIS, 2020-2033
- Hospitals & Clinics
- Dialysis Centers
- Research & Diagnostic Laboratories
- Others
GLOBAL HEPARIN CALCIUM MARKET, BY REGION- MARKET ANALYSIS, 2020-2033
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Table of Contents
1. Heparin Calcium Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Heparin Calcium Market Snippet by Product Type
- 2.1.2. Heparin Calcium Market Snippet by Route of Administration
- 2.1.3. Heparin Calcium Market Snippet by Application
- 2.1.4. Heparin Calcium Market Snippet by End User
- 2.1.5. Heparin Calcium Market Snippet by Country
- 2.1.6. Heparin Calcium Market Snippet by Region
- 2.2. Competitive Insights
3. Heparin Calcium Key Market Trends
- 3.1. Heparin Calcium Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Heparin Calcium Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Heparin Calcium Market Opportunities
- 3.4. Heparin Calcium Market Future Trends
4. Heparin Calcium Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Heparin Calcium Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. Heparin Calcium Market Landscape
- 6.1. Heparin Calcium Market Share Analysis, 2025
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Heparin Calcium Market - By Product Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
- 7.1.2. Unfractionated Heparin (UFH)
- 7.1.3. Low Molecular Weight Heparin (LMWH)
- 7.1.4. Others
8. Heparin Calcium Market - By Route of Administration
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Route of Administration, 2025 & 2033 (%)
- 8.1.2. Subcutaneous Injection
- 8.1.3. Intravenous
- 8.1.4. Others
9. Heparin Calcium Market - By Application
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 9.1.2. Deep Vein Thrombosis
- 9.1.3. Pulmonary Embolism
- 9.1.4. Renal Dialysis
- 9.1.5. Cardiovascular Surgery
- 9.1.6. Others
10. Heparin Calcium Market - By End User
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
- 10.1.2. Hospitals & Clinics
- 10.1.3. Dialysis Centers
- 10.1.4. Research & Diagnostic Laboratories
- 10.1.5. Others
11. Heparin Calcium Market- By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. Heparin Calcium Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.2.8.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.2.9.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. Heparin Calcium Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.8.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.9. UK
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.9.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.9.4. UK Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.9.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.10. France
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.10.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.10.4. France Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.10.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.11. Italy
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.11.4. Italy Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.11.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.12. Spain
- 11.3.12.1. Overview
- 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.12.4. Spain Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.12.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.13. The Netherlands
- 11.3.13.1. Overview
- 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.13.4. The Netherlands Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.14. Sweden
- 11.3.14.1. Overview
- 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.14.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.15. Russia
- 11.3.15.1. Overview
- 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.15.4. Russia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.15.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.16. Poland
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.16.4. Poland Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.16.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.17. Rest of Europe
- 11.3.17.1. Overview
- 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.17.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Heparin Calcium Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.8. China
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.8.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.8.4. China Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.8.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.9. India
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.9.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.9.4. India Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.9.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.10.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.11.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.12.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.13. Indonesia
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.14. Thailand
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.14.4. Thailand Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.14.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.15.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.16. Rest of APAC
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Heparin Calcium Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.5.8.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.5.9.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.5.10.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.5.11.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Heparin Calcium Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.9. United Arab Emirates
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.6.10.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.6.11.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.6.12.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.6.13.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.14. Rest of MEA
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Heparin Calcium Industry
- 12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
- 12.2. Company Profiles
- 12.2.1. Shenzhen Hepalink Pharmaceutical Co., Ltd.
- 12.2.2. Changshan Pharmaceutical
- 12.2.3. Dongcheng Pharmaceutical
- 12.2.4. Cisen Pharmaceutical
- 12.2.5. Changzhou Qianhong Biopharma
- 12.2.6. Nanjing King-friend Biochemical Pharmaceutical
- 12.2.7. Yino Pharma Limited
- 12.2.8. Tianjin Chasesun Pharmaceutical
- 12.2.9. Bioiberica
- 12.2.10. Opocrin S.p.A.
- 12.2.11. Sichuan Deebio Pharmaceutical
- 12.2.12. Dongying Tiandong Pharmaceutical
- 12.2.13. Nanjing Xinbai Pharmaceutical
- 12.2.14. Qingdao Jiulong Biopharmaceutical
- 12.2.15. Pfizer Inc.
- 12.2.16. Others
13. 360 Degree AnalystView
14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
